slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 239,161-239,190
Pages 10,126
Rows per page 30
Component
239,161-239,190 of 303,780
16
The chart breaks down value from existing operations through various development projects to reach an Upside Case and an Adjusted Upside Case.J.P.Morgan | Investment Banking Pitch Book | 32 slides · JPMorgan
Deck Investment bank Beat · Product1 hit
17
The diagram uses a funnel-like shape to show convergence of inputs into a single outcome.J.P.Morgan | Investment Banking Pitch Book | 32 slides · JPMorgan
Deck Investment bank Beat · Solution1 hit
18
The slide uses a chevron-based list format to map risk categories to specific bulleted descriptions.J.P.Morgan | Investment Banking Pitch Book | 32 slides · JPMorgan
Deck Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
19
J.P.Morgan | Investment Banking Pitch Book | 32 slidesJ.P.Morgan | Investment Banking Pitch Book | 32 slides · JPMorgan
Deck Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
20
Includes footnotes detailing calculation methodologies and company-specific adjustments.J.P.Morgan | Investment Banking Pitch Book | 32 slides · JPMorgan
Deck Investment bank Beat · Financials1 hit
21
The table includes equity market value, total market capitalization, debt ratios, and credit ratings for eight companies.J.P.Morgan | Investment Banking Pitch Book | 32 slides · JPMorgan
Deck Investment bank Beat · Financials1 hit
22
The table includes specific deal metrics for seven transactions and median multiples for two industry segments.J.P.Morgan | Investment Banking Pitch Book | 32 slides · JPMorgan
Deck Investment bank Beat · Financials1 hit
23
The slide uses a sum-of-the-parts (SOTP) valuation methodology, aggregating enterprise values from various business units and projects.J.P.Morgan | Investment Banking Pitch Book | 32 slides · JPMorgan
Deck Investment bank Beat · Financials1 hit
24
Includes valuation tables for existing operations, development projects, Palmilla, undeveloped land, and valuation ranges.J.P.Morgan | Investment Banking Pitch Book | 32 slides · JPMorgan
Deck Investment bank Beat · Financials1 hit
25
J.P.Morgan | Investment Banking Pitch Book | 32 slidesJ.P.Morgan | Investment Banking Pitch Book | 32 slides · JPMorgan
Deck Investment bank Beat · Financials1 hit
26
The slide compares internal land holdings with external market transactions to establish a valuation benchmark.J.P.Morgan | Investment Banking Pitch Book | 32 slides · JPMorgan
Deck Investment bank Beat · Financials1 hit
27
The slide presents two distinct valuation models side-by-side, with a summary calculation for Atlantis projects at the bottom.J.P.Morgan | Investment Banking Pitch Book | 32 slides · JPMorgan
Deck Investment bank Beat · Financials1 hit
28
The table includes quarterly data for 2006 and annual data for other years.J.P.Morgan | Investment Banking Pitch Book | 32 slides · JPMorgan
Deck Investment bank Beat · Financials1 hit
29
Includes detailed segment-level EBITDA, corporate expenses, and reconciliation adjustments to GAAP EBITDA.J.P.Morgan | Investment Banking Pitch Book | 32 slides · JPMorgan
Deck Investment bank Beat · Financials1 hit
30
Includes WACC calculation, peer beta table, and a sensitivity matrix for WACC based on beta and cost of debt.J.P.Morgan | Investment Banking Pitch Book | 32 slides · JPMorgan
Deck Investment bank Beat · Financials1 hit
31
Details tax asset valuation and Section 382-style limitations.J.P.Morgan | Investment Banking Pitch Book | 32 slides · JPMorgan
Deck Investment bank Beat · Financials1 hit
32
The table includes room metrics, gaming revenue (Win/Table/Day, Slot Win/Day), and various F&B and expense ratios.J.P.Morgan | Investment Banking Pitch Book | 32 slides · JPMorgan
Deck Investment bank Beat · Financials1 hit
02
J.P.Morgan | Investment Banking Pitch Book | 5 slidesJ.P.Morgan | Investment Banking Pitch Book | 5 slides · JPMorgan
Consulting deck Investment bank 1 hit
03
Project Plato, JPMorgan internal document.J.P.Morgan | Investment Banking Pitch Book | 5 slides · JPMorgan
Consulting deck Investment bank Beat · Problem & Complication1 hit
04
Includes a table of implied share prices and P/E ratios below the chart.J.P.Morgan | Investment Banking Pitch Book | 5 slides · JPMorgan
Consulting deck Investment bank Beat · Evidence & Proof1 hit
05
Project Plato branding present. Data tables compare standalone vs 45%, 55%, and 65% debt/cap scenarios.J.P.Morgan | Investment Banking Pitch Book | 5 slides · JPMorgan
Consulting deck Investment bank Beat · Evidence & Proof1 hit
02
Theranos | Start Up Pitch Deck | 24 slidesTheranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations 1 hit
03
The slide lists specific deal counts and revenue projections for validation and phase IV stages.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations 1 hit
05
The slide features photos of the proprietary hardware and a line chart comparing 'Competitive' vs 'Two Step' assay performance.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations 1 hit
08
The slide highlights key performance metrics like sample size, assay time, and precision.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations Beat · Solution1 hit
09
Theranos | Start Up Pitch Deck | 24 slidesTheranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations Beat · Solution1 hit
10
The slide illustrates a failure case (drug toxicity) to justify the value of the Theranos monitoring system.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations 1 hit
11
The chart shows a 'Second course (Drug dose reduced)' with three series: dose, drug level, and target.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations 1 hit
12
The chart shows a comparison between a 'first course' (uncontrolled) and a 'corrected' course where the drug level is managed.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations 1 hit
13
The chart illustrates a feedback loop: drug dose is reduced when toxicity markers exceed the alert level, successfully bringing toxicity down.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations 1 hit